Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) Return on Invested Capital (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Return on Invested Capital for 6 consecutive years, with 1.82% as the latest value for Q3 2025.

  • Quarterly Return on Invested Capital changed N/A to 1.82% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.82% through Sep 2025, changed N/A year-over-year, with the annual reading at 1.9% for FY2019, 100.0% up from the prior year.
  • Return on Invested Capital for Q3 2025 was 1.82% at Outlook Therapeutics, up from 1.17% in the prior quarter.
  • The five-year high for Return on Invested Capital was 1.82% in Q3 2025, with the low at 1.17% in Q1 2025.